Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
Impact in
- Cancer Research 218
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w80628841 →Countries where authors are citing Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
This map shows the geographic impact of Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. more than expected).
Fields of papers citing Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
This network shows the impact of Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies..
About Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
This paper, published in 2000, received 610 indexed citations . Written by A. Eberhard, Valentin Goede, Bernhard Hemmerlein, Karl H. Plate and Hellmut G. Augustin covering the research area of Molecular Biology and Cancer Research. It is primarily cited by scholars working on Molecular Biology (398 citations), Cancer Research (218 citations), Oncology (177 citations), Pulmonary and Respiratory Medicine (103 citations) and Radiology, Nuclear Medicine and Imaging (89 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w80628841.